Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate the pharmacokinetics of Tipranavir and its metabolites including excretion
and mass balance of parent compound and radioactivity at steady-state; to isolate, identify
and quantify major metabolites of tipranavir in plasma, urine and feces